Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / RLAY - Relay Therapeutics: Heavily Backed Biotech Brains Trust Looks A Long-Term Buy


RLAY - Relay Therapeutics: Heavily Backed Biotech Brains Trust Looks A Long-Term Buy

Investment Thesis

Relay Therapeutics share price performance since IPO

(Source: TradingView)

Investors looking to place a bet on the next big biotech trend may want to take a close look at Relay Therapeutics (RLAY), a novel drug discovery startup with a strong management team, access to one of the world's most powerful supercomputers, and nearly $1 billion in funding, having completed the third-largest biotech IPO of all time in mid-July.

Relay's upsized IPO raised $400 million after the company sold 20 million shares for $20 - above the marketed range of $18-19

Read more ...

Stock Information

Company Name: Relay Therapeutics Inc.
Stock Symbol: RLAY
Market: NASDAQ
Website: relaytx.com

Menu

RLAY RLAY Quote RLAY Short RLAY News RLAY Articles RLAY Message Board
Get RLAY Alerts

News, Short Squeeze, Breakout and More Instantly...